Wedge Capital Management L L P Eli Lilly & CO Transaction History

Wedge Capital Management L L P

$5.04 Billion
Q1 2025

A detailed history of Wedge Capital Management L L P transactions in Eli Lilly & CO stock. As of the latest transaction made, Wedge Capital Management L L P holds 738 shares of LLY stock, worth $595,706. This represents 0.01% of its overall portfolio holdings.

Number of Shares

738

Previous 648 13.89%

Holding current value

$595,706

Previous $500,000 21.8%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$725.72 - $929.72 $65,314 - $83,674	90 Added 13.89%	738 $609,000
Q4 2024 Jan 15, 2025	SELL	$727.2 - $932.06 $165,801 - $212,509	-228 Reduced 26.03%	648 $500,000
Q3 2024 Oct 11, 2024	BUY	$772.14 - $960.02 $22,392 - $27,840	29 Added 3.42%	876 $776,000
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $2,174 - $2,727	-3 Reduced 0.35%	847 $766,000
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $49,152 - $65,759	83 Added 10.82%	850 $661,000
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $13,654 - $16,097	-26 Reduced 3.28%	767 $447,000
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $283,424 - $390,743	-652 Reduced 45.12%	793 $425,000
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $12,626 - $16,883	-36 Reduced 2.43%	1,445 $677,000
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $1,242 - $1,459	-4 Reduced 0.27%	1,481 $508,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $9,003 - $10,490	28 Added 1.92%	1,485 $543,000
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $18,085 - $20,610	-61 Reduced 4.02%	1,457 $471,000
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $16,897 - $20,999	-72 Reduced 4.53%	1,518 $435,000
Q3 2021 Oct 14, 2021	SELL	$221.6 - $272.71 $3,767 - $4,636	-17 Reduced 1.06%	1,590 $367,000
Q2 2021 Jul 14, 2021	SELL	$180.55 - $233.54 $59,942 - $77,535	-332 Reduced 17.12%	1,607 $369,000
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $46,831 - $60,625	-285 Reduced 12.81%	1,939 $362,000
Q4 2020 Jan 08, 2021	BUY	$130.46 - $172.63 $12,002 - $15,881	92 Added 4.32%	2,224 $376,000
Q3 2020 Oct 08, 2020	BUY	$146.22 - $169.13 $19,447 - $22,494	133 Added 6.65%	2,132 $316,000
Q2 2020 Jul 10, 2020	SELL	$136.42 - $164.18 $4,229 - $5,089	-31 Reduced 1.53%	1,999 $328,000
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $8,690 - $10,756	-73 Reduced 3.47%	2,030 $282,000
Q4 2019 Jan 15, 2020	BUY	$106.92 - $132.43 $1,389 - $1,721	13 Added 0.62%	2,103 $276,000
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $7,261 - $7,898	68 Added 3.36%	2,090 $234,000
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $224,017 - $261,485	2,022 New	2,022 $224,000

Others Institutions Holding LLY

# of Institutions

4,393

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $767B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Account

Wedge Capital Management L L P Eli Lilly & CO Transaction History